NCT05335369Completed
A Patient-Centered Communication Tool (UR-GOAL) Versus Usual Care for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
A Pilot Randomized Controlled Trial of a Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
Source: ClinicalTrials.gov · Last updated 11 May 2026
Brief summary (registry, in English)
The objective of this study is to evaluate the preliminary efficacy of the UR-GOAL tool in improving shared decision making and communication between older patients with AML and their oncologists in a pilot randomized trial.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 161 (actual)
- First submitted
- 12 Apr 2022
- Start date
- 17 Jun 2022
- Primary completion date
- 7 Apr 2025
- Lead sponsor
- University of Rochester
- Diseases
- Acute myeloid leukemia
- NCT number
- NCT05335369
What you commit to
- Study type: Interventional
- Participants enrolled: 161
- From 17 Jun 2022 to the primary completion date, 7 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Patients
- Age ≥60 years
- Newly diagnosed AML or being worked up for possible AML
- Able to provide informed consent
- Agreement of their oncologist to participate in the study
- English-speaking
- If patients screen positive for cognitive impairment on the Mini-Cog test performed as part of the baseline assessment, they can still enroll if they are able to provide informed consent and have decision making capacity as determined by their treating oncologist
- Caregivers
- Selected by the patient when asked if there is a "family member, partner, friend or caregiver \[age 21 or older\] with whom the patient discuss or who can be helpful in health-related matters;" patients who cannot identify such a person ("caregiver") can be eligible for the study. A caregiver need not be someone who lives with the patient or provides direct hands-on care. A caregiver can be any person who provides support (in any way) to the patient
- Able to provide informed consent
- English-speaking
- Oncologists
- A practicing oncologist
- At least one of their patients are recruited to the study
- English-speaking
Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Rochester Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
Related publications
- Patient and oncologist expectations of functional prognosis among older adults with acute myeloid leukemia.Blood Adv · 2026 · PMID 42275539
This page is information, not medical advice. Discuss any trial with your doctor.